By Drug Target Review –
Shift Bioscience has announced new aging research, highlighting the discovery of SB000. This novel single-gene target reverses cellular aging without activating dangerous pluripotency pathways.
Shift Bioscience, a biotechnology company, uses dataset-driven discovery to understand and manipulate cell rejuvenation. They recently announced that SB000 demonstrates a powerful rejuvenating effect across multiple cell types. Crucially, the gene induces this rejuvenation without activating the dangerous pluripotency pathways triggered by current approaches such as the Yamanaka Factors (OSKM).
